Urologic Care Market Size, Share, Opportunities, And Trends By Product Type (Urology Implants, Urology Devices And Instruments, Urology Consumables), By Disease Type (Benign Prostatic Hyperplasia (Bph), Prostate Cancer, Kidney Stones, Urinary Incontinence, Bladder Cancer, Erectile Dysfunction, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Urology Specialty Centers, Others), And By Geography - Forecasts From 2023 To 2028

The urologic care market is estimated to grow at a CAGR of 6.52% during the forecast period.

The urologic care market, which focuses on the prevention, diagnosis, and treatment of urologic illnesses, is a major component of the healthcare business. This market includes a wide range of medical devices, drugs, and services focused at treating urinary system and male reproductive organ disorders. With the rising prevalence of urologic disorders such as urinary tract infections, kidney stones, and prostate cancer, there is an increased demand for appropriate urologic care solutions. Medical technology advancements, minimally invasive procedures, and personalised therapies have all contributed to the market's rise. The urologic care market is critical to increasing patient quality of life and ensuring optimal urologic health.

Rising Demand for Minimally Invasive Urologic Procedures Enhances the Urologic Care Market Growth.

Its advantages over traditional surgical treatments, the urologic care market is seeing a spike in demand for minimally invasive procedures. Minimally invasive procedures, such as laparoscopy and robotic-assisted operations, provide lower postoperative discomfort, shorter hospital stays, quicker recovery, and better aesthetic outcomes. Patients seek these operations for illnesses such as kidney stones, prostate diseases, and urinary tract concerns. Furthermore, healthcare professionals favour minimally invasive techniques since they result in better patient outcomes and lower healthcare expenditures. Growing knowledge of the benefits of these treatments, along with developments in urologic medical technology, has spurred increased demand, resulting in market growth and the proliferation of minimally invasive choices in urologic care.

Adoption of Personalized and Precision Medicine Approaches in Urologic Care Market.

To improve patient outcomes and treatment efficacy, the urologic care market is embracing personalised and precision medicine techniques. Precision medicine in urology is gaining traction, particularly in the treatment of prostate cancer, according to research published in the journal European Urology. The use of genomic profiling and biomarker analysis to personalise therapeutics results in more focused and effective treatments. Furthermore, personalised medicine enables healthcare practitioners to construct customised care regimens by considering specific patient features, medical history, and genetic variables. Precision medicine is gaining significance in urologic care because it adds to greater patient satisfaction, better treatment responses, and fewer side effects, which is driving market expansion in this area.

Expanding Healthcare Access and Patient-Centric Care Models Boosts the Urologic Care Market Size

To serve a larger patient population, the urologic care market is extending healthcare access and implementing patient-centric care models. With the increasing frequency of urologic illnesses, there is a greater emphasis on expanding access to specialised treatment and minimising healthcare inequities. Telemedicine and digital health platforms are being used to reach patients in remote locations, allowing for virtual consultations and follow-ups. Furthermore, patient-centric care models place a premium on individual needs, choices, and participation in treatment decision-making. These methods emphasise complete care, which includes education, emotional support, and personalised treatment regimens. The urologic care market intends to improve patient outcomes, increase patient happiness, and satisfy the population's different healthcare demands by implementing these patient-centric techniques.

North America is the Market Leader in the Urologic Care Market

The urologic care market is dominated by North America. Several factors contribute to the region's significance. For starters, there is a significant frequency of urologic problems, such as urinary tract infections, kidney stones, and prostate issues, which increases the demand for urologic care solutions. Second, North America has a well-developed healthcare infrastructure and superior medical technology, which facilitates the implementation of novel urologic therapies and procedures. Furthermore, the area places a major emphasis on research and development, which contributes to the continual advancement of urologic care. Furthermore, favourable reimbursement policies and rising urologic health awareness fuel the market's expansion. North America continues to be a vital urologic care centre, delivering comprehensive services to patients and promoting urologic healthcare practises.

Increasing Prevalence of Urologic Disorders in Urologic Care Market

The global frequency of urologic illnesses is driving growth in the urologic care market. Urologic illnesses impact millions of people worldwide, according to the National Institutes of Health (NIH), with conditions such as urinary tract infections, kidney stones, and prostate troubles being particularly common. Sedentary lifestyles, bad diets, and ageing populations have all led to an increase in urologic illnesses. As a result, urologic care options, such as medical devices, medications, and therapies, are in increased demand. The rising prevalence of urologic illnesses has prompted investments in research & development to meet the challenges faced by these ailments, propelling the urologic care market forward.

Key Developments:

• In June 2023, Olympus Corporation ("Olympus") now announces that it has chosen to conduct an absorption type merger with its consolidated subsidiary, Olympus Digital System Design Corp. ("Olympus Digital System Design"), beginning October 1, 2023, as indicated below (the "Merger").
• In February 2023, KARL STORZ, a family-owned medical technology firm, has announced the acquisition of 100% of the shares in AventaMed DAC, an Irish medical technology company. AventaMed is headquartered in Cork, where it was founded in 2015 after being spun out of Munster Technological University. The Solo+ TTD was created after the firm received financing backing from Enterprise Ireland and other angel investors based mostly in Ireland. It is a ground-breaking single-use medical gadget that tackles the pain points of existing ENT surgical tympanostomy therapy to enable an altogether new mode of treatment. The parties agreed not to reveal the acquisition price.
• In April 2023, RIWOlink, a newly created Richard Wolf subsidiary for all Digital Products in and around the OR, joins forces with Sony Healthcare Solutions Europe (HSE) to develop innovative OR Integration technology. The Sony NUCLeUSTM Platform will be a cornerstone of the RIWOlink System in this collaboration for all video management and communication requirements in the digital OR. RIWOlink will include NUCLeUS into its operating system architecture, resulting in a strong solution with a fully integrated user interface for all data management, device control, and communication requirements in and around the OR. 

Company Products:

• Urologic Medical Devices: Stryker has a diverse portfolio of urologic medical devices, including as ureteral stents, nephrostomy catheters, and stone retrieval devices, which are used to treat urinary tract blockages and kidney stones.
• Urologic Imaging Systems: Siemens Healthineers provides modern urologic imaging equipment, such as ultrasound and computed tomography (CT) scanners, for precise diagnosis and treatment planning.
• Urologic Endoscopy Systems: Olympus offers innovative endoscopic equipment built exclusively for urologic operations, such as flexible ureteroscopes and cystoscopes. These gadgets allow for less invasive urinary tract visualisation and therapy.
• Urologic Medical Devices: Medtronic manufactures a comprehensive range of urologic medical devices, such as urinary catheters, stents, and access sheaths, which are used in the treatment of urological illnesses such as urinary tract blockage and kidney stones.

Key Segment:

• By Product Type
  • Urology Implants
  • Urology Devices And Instruments
  • Urology Consumables    
• By Disease Type
  • Benign Prostatic Hyperplasia (Bph)
  • Prostate Cancer
  • Kidney Stones
  • Urinary Incontinence
  • Bladder Cancer
  • Erectile Dysfunction
  • Others 
• By End-User
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Urology Specialty Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain   
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Sources

2.3. Research Design

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. UROLOGIC CARE MARKET, BY PRODUCT TYPE 

5.1. Introduction

5.2. Urology Implants

5.3. Urology Devices and Instruments

5.4. Urology Consumables                 

6. UROLOGIC CARE MARKET, BY DISEASE TYPE

6.1. Introduction

6.2. Benign Prostatic Hyperplasia (BPH)

6.3. Prostate Cancer

6.4. Kidney Stones

6.5. Urinary Incontinence

6.6. Bladder Cancer

6.7. Erectile Dysfunction

6.8. Others              

7. UROLOGIC CARE MARKET, BY END-USER

7.1. Introduction

7.2. Hospitals and Clinics

7.3. Ambulatory Surgical Centers

7.4. Urology Specialty Centers

7.5. Others            

8. UROLOGIC CARE MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia 

8.6.6. Taiwan

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Boston Scientific Corporation

10.2. Medtronic plc

10.3. Olympus Corporation

10.4. Cook Medical LLC

10.5. Becton, Dickinson and Company (BD)

10.6. Coloplast Group

10.7. C. R. Bard, Inc. (acquired by Becton, Dickinson and Company)

10.8. Karl Storz SE & Co. KG

10.9. Teleflex Incorporated

10.10. Terumo Corporation    

Boston Scientific Corporation

Medtronic Plc

Olympus Corporation

Cook Medical Llc

Becton, Dickinson And Company (Bd)

Coloplast Group

C. R. Bard, Inc. (Acquired By Becton, Dickinson And Company)

Karl Storz Se & Co. Kg

Teleflex Incorporated